Key statistics
As of last trade, Edwards Lifesciences Corp (EWLS:VIE) traded at 61.65, 13.12% above the 52 week low of 54.50 set on Aug 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 61.18 |
---|---|
High | 61.65 |
Low | 60.98 |
Bid | 61.39 |
Offer | 61.92 |
Previous close | 60.92 |
Average volume | 23.29 |
---|---|
Shares outstanding | 589.80m |
Free float | 584.39m |
P/E (TTM) | 27.97 |
Market cap | 39.06bn USD |
EPS (TTM) | 2.37 USD |
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Press releases
- Data Presented at TCT Reinforce Edwards Lifesciences’ Commitment to Structural Heart Innovation
- TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-life Benefits With Edwards EVOQUE System for Severe Tricuspid Regurgitation
- Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients
- Edwards Lifesciences Reports Third Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on October 24, 2024
- Edwards Lifesciences Completes Sale of Critical Care
- CORRECTING and REPLACING First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves
- Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference
More ▼